Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iscador P infusion in advanced cancer
NCT04376931Phase 2Unknown
- Sponsor
- Emek Medical Center
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of Iscador P in solid tumor (advanced stage), sponsored by Emek Medical Center. Status: unknown.
02
Drugs
Iscador P
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT04376931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04376931.